CONGRATULATION ON FIRST PATIENT RANDOMIZED IN MALAYSIA [BI 1366-0022]

Congratulations Associate Prof. Dr. Lim Soo Kun and the study team on the First Patient Randomized in Malaysia for the 1366-0022 study (non-diabetic CKD) study!!
Million thanks for all the hard work and efforts throughout the journey. It is deeply meaningful to UMMC and the nation

Details of the study: BI 1366-0022 Trials

BeAHero, CICUMMC, ClinicalInvestigationCentre, ClinicalResearch, ClinicalResearchinMalaysia, ClinicalTrials, DiabeticNephropathiesDisease, LeaderinClinicalResearch, Malaysia, Nephrology, Recruiting

ZENITH High Proteinuria Study: Outstanding Achievement by UMMC Team

We are proud to announce a remarkable milestone for Universiti Malaya Medical Centre (UMMC) in the ZENITH High Proteinuria (D4325C00010) study. Under the leadership of

OPERA-1 Clinical Trial: UMMC Achieves Top Enroller Recognition

We are thrilled to announce that Universiti Malaya Medical Centre (UMMC), under the leadership of Assoc. Prof. Dr. Rozita Binti Abdul Malik, has been recognized

MSD and UMMC Clinical Trial Partnership Meeting: Strengthening Collaboration in Clinical Research

This morning, the Clinical Investigation Centre (CIC) at Universiti Malaya Medical Centre (UMMC) hosted the MSD and UMMC Clinical Trial Partnership Meeting, a significant step

ASCENT-07 : Outstanding Study Achievement in 2024

We are proud to celebrate the exceptional achievements of Assoc. Prof. Dr. Adlinda Alip and her dedicated team at Universiti Malaya Medical Centre (UMMC) in

CONGRATULATION ON FIRST PATIENT RANDOMIZED IN MALAYSIA [BI 1366-0022]

Share:

More Posts

ZENITH High Proteinuria Study: Outstanding Achievement by UMMC Team

OPERA-1 Clinical Trial: UMMC Achieves Top Enroller Recognition

MSD and UMMC Clinical Trial Partnership Meeting: Strengthening Collaboration in Clinical Research

ASCENT-07 : Outstanding Study Achievement in 2024

Newsletter